Multitargeted tyrosine kinase inhibitor stimulates expression of IL-6 and activates JAK2/STAT5 signaling in acute myelogenous leukemia cells
- 13 August 2009
- journal article
- letter
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 23 (12), 2304-2308
- https://doi.org/10.1038/leu.2009.163
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Inhibition of Flt3‐activating mutations does not prevent constitutive activation of ERK/Akt/STAT pathways in some AML cells: a possible cause for the limited effectiveness of monotherapy with small‐molecule inhibitorsHematological Oncology, 2006
- STI 571 inhibition effect on KITAsn822Lys-mediated signal transduction cascadeExperimental Hematology, 2005
- Establishment of a human acute myeloid leukemia cell line (Kasumi-1) with 8;21 chromosome translocationBlood, 1991
- A multiple cytokine- and second messenger-responsive element in the enhancer of the human interleukin-6 gene: similarities with c-fos gene regulation.Molecular and Cellular Biology, 1989